KURE KraneShares MSCI All China Health Care Index ETF Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
06:24
Aug 06
Aug 06
Rotation into Chinese domestic insurers
A rotation from banks into domestic Chinese insurance companies is expected as yield-seeking investors turn to insurance investment products. Additionally, many Chinese companies have begun buybacks and corporate governance improvements, making dividend stocks attractive for positive carry. Domestic insurers should benefit from this shift.
MED
05:01
Aug 04
Aug 04
Chinese healthcare offers best earnings visibility
The Chinese healthcare sector has the best earnings visibility in China this year. While market attention chased AI, healthcare offers real earnings growth, particularly in obesity, and AI is now providing additional tailwinds for drug discovery efficiency.
MED
07:08
Apr 16
Apr 16
Health care in EMs has growth potential.
Health care sector in emerging markets, particularly in China, has strong growth potential due to aging populations and increasing domestic demand for medical services and drugs.
MED
15:01
Feb 06
Feb 06
Big Pharma is increasingly buying early-stage assets from China (30-40% of acquisitions vs. single digits previously). Clinical trials in China are significantly cheaper and faster. China has successfully built a biotech infrastructure that is now integrating into the global supply chain. As US/EU firms outsource early development to China for speed/cost, Chinese biotech firms become prime M&A targets or dominant players in early-stage discovery. LONG. This is a contrarian play on Chinese innovation capabilities rather than just consumer demand. Geopolitical tensions; regulatory changes regarding data acceptance (though currently improving); US restrictions on Chinese biotech.
About KURE Analyst Coverage
Buzzberg tracks KURE (KraneShares MSCI All China Health Care Index ETF) across 2 sources. 4 bullish vs 0 bearish calls from 4 analysts. Sentiment: predominantly bullish (100%). 4 total trade ideas tracked. Latest voices: Eva Lee, Cui Cui, Ed Yardeni.